Cogent Biosciences, Inc.

COGT

NASDAQBiotechnology🇺🇸North America

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Drug Pipeline

Drug Name	Phase	Indication	Designations
CGT9486 plus sunitinib	Phase 3	Advanced Gastrointestinal Stromal Tumors	-
bezuclastinib	Phase 2	Advanced Systemic Mastocytosis (AdvSM)	-
CGT9486	Phase 2	Gastrointestinal Stromal Tumors	-
Bezuclastinib Tablets (Formulation A)	Phase 2	SSM	-
CGT4859	Phase 2	Intrahepatic Cholangiocarcinoma (Icc)	-

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Regulatory Approvals

COGT News